Skip to main content
Clinical Trials/ISRCTN17751649
ISRCTN17751649
Active, not recruiting
未知

Enhanced cognitive behavioural therapy for self-harm among people with comorbid mental and physical health conditions: a pragmatic randomised controlled trial

Health Research Board0 sites180 target enrollmentAugust 21, 2024

Overview

Phase
未知
Intervention
Not specified
Conditions
Self-harm and suicidal behaviours (ideation and act) in comorbid physical and mental health conditions
Sponsor
Health Research Board
Enrollment
180
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 21, 2024
End Date
October 1, 2026
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Adults over 18 years
  • 2\. Presence of a chronic physical illness(es) requiring the services of secondary/ tertiary care, specifically, cancer or asthma or Chronic Obstructive Pulmonary Disease (COPD) or any type of chronic pain (including fibromyalgia, trauma, or osteoarthritis) persisting over 3 months or defined as per ICD\-11
  • 3\. A recent history (within the past 3 months) or risk of self\-harm or suicidal behaviors (ideation and act)
  • 4\. Presence of comorbid mental health symptom(s) such as anxiety, mild\-moderate depressive symptoms, or distress

Exclusion Criteria

  • 1\. Below the age of 18 years
  • 2\. Not requiring or undergoing secondary treatment
  • 3\. Not living with a chronic physical illness including non\-melanoma skin cancer
  • 4\. Exhibiting high/severe risk of suicidal or self\-harm behaviours, where the treating consultant doesn’t recommend participation in the study
  • 5\. Diagnosed with severe or enduring mental disorders like severe depression or anxiety (score of 9 or more on PHQ\-4 screening test), schizophrenia, bipolar affective disorders, personality disorders
  • 6\. Significant cognitive impairment
  • 7\. Requiring intensive in\-patient care due to their medical illness

Outcomes

Primary Outcomes

Not specified

Similar Trials